NCT07476053

Brief Summary

The purpose of this study is to examine the relationship between daily light exposure patterns, sleep quality, and migraine characteristics in adults with migraine, with and without photophobia, across an 8-week study period.

Trial Health

77
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
20

participants targeted

Target at below P25 for not_applicable

Timeline
8mo left

Started Mar 2026

Geographic Reach
1 country

1 active site

Status
recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress24%
Mar 2026Mar 2027

First Submitted

Initial submission to the registry

March 8, 2026

Completed
9 days until next milestone

First Posted

Study publicly available on registry

March 17, 2026

Completed
7 days until next milestone

Study Start

First participant enrolled

March 24, 2026

Completed
11 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

March 1, 2027

Expected
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

March 1, 2027

Last Updated

April 28, 2026

Status Verified

April 1, 2026

Enrollment Period

11 months

First QC Date

March 8, 2026

Last Update Submit

April 23, 2026

Conditions

Keywords

MigraineSleepLightingPhotophobia

Outcome Measures

Primary Outcomes (1)

  • Change in Monthly Migraine Days

    Number of migraine days per 28-day period as recorded in daily electronic headache diaries. A migraine day is defined as a calendar day with a self-reported migraine meeting International Classification of Headache Disorders (ICHD-3) criteria. The primary analysis will compare the 4-week baseline period to the 4-week intervention period within participants.

    Baseline (Weeks 1-4) compared to Intervention (Weeks 5-8)

Secondary Outcomes (7)

  • Change in Migraine Headache Intensity

    Baseline (Weeks 1-4) compared to Intervention (Weeks 5-8)

  • Change in Migraine-Specific Quality of Life (MSQ v2.1) Score

    Baseline (Week 0), Between Baseline and Intervention (end of Week 4), and End of Intervention (Week 8).

  • Change in Objective Sleep Efficiency

    Baseline (Weeks 1-4) compared to Intervention (Weeks 5-8)

  • Change in Average Daily Ambient Light Intensity

    Baseline (Weeks 1-4) compared to Intervention (Weeks 5-8)

  • Feasibility of Workplace Lighting Intervention

    Intervention Period (Weeks 5-8)

  • +2 more secondary outcomes

Study Arms (1)

Optimized Lighting Intervention

EXPERIMENTAL

All participants will complete a 4-week baseline observation period followed by a 4-week intervention period. During the baseline period, daily light exposure, sleep, and migraine characteristics will be monitored under natural conditions. During the intervention period, participants will use an optimized workplace lighting condition during working hours while continuing wearable monitoring and daily electronic surveys. Outcomes during the intervention period will be compared to baseline measurements within participants.

Other: Ambient Lighting Condition

Interventions

Application of an optimized ambient lighting condition through placement of a dimmable LED floor lamp in participants' private workspaces to create a standardized workplace lighting environment during working hours. The floor lamp emits white light with a specified spectral distribution and intensity. Participants may adjust brightness for comfort. The lighting system is used solely to modify the ambient workplace lighting environment during the 4-week intervention period.

Optimized Lighting Intervention

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Meet the International Classification of Headache Disorders, 3rd edition (2018) criteria for migraine, with or without aura or photosensitivity
  • Report experiencing more than 4 headache days per month and at least three migraine attacks per month
  • No other major health issues based on self-reported data
  • Able to read and communicate in English
  • Work in a private office space for at least six hours per day, four days per week

You may not qualify if:

  • Light therapy
  • Use light-altering devices (e.g., blue-blocking contact lenses or glasses)
  • Traveling out of town during the participation

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

ASU DeSmart Lab

Tempe, Arizona, 85281, United States

RECRUITING

MeSH Terms

Conditions

Migraine DisordersPhotophobia

Condition Hierarchy (Ancestors)

Headache Disorders, PrimaryHeadache DisordersBrain DiseasesCentral Nervous System DiseasesNervous System DiseasesVision DisordersSensation DisordersNeurologic ManifestationsEye DiseasesSigns and SymptomsPathological Conditions, Signs and Symptoms

Study Officials

  • Nina Sharp, PhD

    Arizona State University

    PRINCIPAL INVESTIGATOR

Central Study Contacts

Nina Sharp, PhD

CONTACT

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NA
Masking
NONE
Purpose
OTHER
Intervention Model
SINGLE GROUP
Model Details: This is a single-arm, repeated-measures interventional study. All participants will complete a 4-week baseline observation period during which daily light exposure, sleep patterns, and migraine characteristics are monitored under naturalistic conditions. This will be followed by a 4-week intervention period during which an optimized workplace lighting condition will be introduced. Participants will continue wearable monitoring and daily electronic surveys throughout both phases. Outcomes during the intervention period will be compared to each participant's baseline measurements.
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Assistant professor

Study Record Dates

First Submitted

March 8, 2026

First Posted

March 17, 2026

Study Start

March 24, 2026

Primary Completion (Estimated)

March 1, 2027

Study Completion (Estimated)

March 1, 2027

Last Updated

April 28, 2026

Record last verified: 2026-04

Locations